NEPTUNE DIGITAL ASSETS CORP
NPPTF
Abits
ABTS
Ebang International
EBON
Canaan
CAN
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
NEUP Neuphoria Therapeutics
- 4.100
- -2.530-38.16%
Trading Dec 26 10:27 ET
6.67MMarket Cap-0.27P/E (TTM)
4.993High3.900Low319.05KVolume4.900Open6.630Pre Close1.37MTurnover22.88%Turnover RatioLossP/E (Static)1.63MShares18.00052wk High0.39P/B5.72MFloat Cap2.12452wk Low--Dividend TTM1.39MShs Float264.000Historical High--Div YieldTTM16.48%Amplitude2.112Historical Low4.296Avg Price1Lot Size
Neuphoria Therapeutics Key Stats
EPS
According to the latest financial report of Neuphoria Therapeutics, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Neuphoria Therapeutics's free cash flow? The latest report shows it as -4.43M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Neuphoria Therapeutics shows that the company's current ratio is 3.30, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Neuphoria Therapeutics, the quick ratio is 3.21, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Neuphoria Therapeutics? The latest ROE figure is -4.66%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Neuphoria Therapeutics, the total asset return on investment (ROA) is -3.18%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Neuphoria Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Neuphoria Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
